In-house roundup: anti-anti-suit injunction filers reveal insights; US-UK trade documents unpacked; open source case spurs NPE fear

Email a friend Your name:

Your email:

Please enter a maximum of 5 recipients. Use ; to separate more than one email address.

Recipient email(s):

Recipient name(s):

Email yourself a copy?

06 December 2019 |

Patrick Wingrove, London

Managing IP rounds up the latest news and analysis from patent-focused businesses

Money

Anti-anti-suit injunctions: filers reveal importance of new orders

IPCom, Nokia and two car companies say the success of the new order shows that forum-shopping does not fly with European courts and – if that continues – anti-suit injunctions will not become popular as a ‘stalling tool’. Read more...

What the US-UK trade deal documents actually reveal

Generics and innovator sources from the pharma industry explain why documents from US and UK trade discussions do not point to the US trying to extend pharmaceutical patents. Read more...

Open source case prompts patent troll litigation fears

Software stakeholders including the Linux Foundation, Qualcomm and Unified Patents are concerned that RPI v Gnome has opened the door to open source NPE litigation. Read more...

Dismantling the patent system not a 'silver bullet' to lower drug prices

In-house counsel from pharma innovators say the IP system is unfairly under attack for rising drug prices and that new drugs will not reach the market without patents. Read more...

Comments

Display this name

Notify me of follow up comments

I have read and agree to the terms & conditions.

{{article|snippet:'title'|removeHtmlTags}}

{{article|fields:'dates'|date:dateArticleFormat}} | {{article|fields:'authors'}}

In-house roundup: anti-anti-suit injunction filers reveal insights; US-UK trade documents unpacked; open source case spurs NPE fear

Anti-anti-suit injunctions: filers reveal importance of new orders

What the US-UK trade deal documents actually reveal

Open source case prompts patent troll litigation fears

Dismantling the patent system not a 'silver bullet' to lower drug prices

Comments

Related Articles

Most read articles

AI inventorship denial not surprising but is step towards change

UK SPC ruling pushes patent drafting specificity

SEP remedy policy ‘reversal’ emboldens US patent owners

Cannabis filers hash over FTO and future enforcement

Open source case prompts patent troll litigation fears

Latest Country Updates

IP STARS 2020 research and webinar

EPO: Appeal Board vetoes EPC regulation

Germany: Court blocks prior art time travel

Turkey: Is a public interest compulsory licence on the way?

Russia: Chamber of Patent Disputes cancels design on second attempt

Canada: Two different approaches to patent applications

Patent Q&A sponsored by Wanhuida – Peksung

IP High Court gives new ruling on patent term extension

How to deal with IP enforcement challenges in Indonesia

Belgium - The (too) effective Belgian descriptive seizures

Supplements

Americas IP Focus 2019

Asia-Pacific 2019 IP Focus

Japanese Buyers’ Guide 2019

Future of IP – Artificial Intelligence 2019

Turkey IP Focus 2019

About Managing IP

My Managing IP

Resources

Site Policies

In-house roundup: anti-anti-suit injunction filers reveal insights; US-UK trade documents unpacked; open source case spurs NPE fear

Comments

Related Articles

Most read articles

Latest Country Updates

Supplements

Welcome to Managing Intellectual Property